• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks

firstwordpharmaJuly 12, 2021

Tag: OMT , COVID-19 , Vaccine

The Netherlands' Outbreak Management Team (OMT) expressed doubts about whether Johnson & Johnson's single-dose COVID-19 vaccine offers sufficient protection against the Delta variant, reported NL Times.

OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks

"It is still questionable to what extent it indeed offers full immunity against the Delta variant 14 days after vaccination," the OMT commented, according to the ANP.

The OMT emphasized that the majority of young people follow coronavirus regulations.

According to the group, the tightened measures must be maintained until mid-August, when everyone has been vaccinated at least once.


Previous:Japan releases study on 'Moderna arm' reaction

Next:COVID-19 vaccines highly effective in most people in clinical risk groups

Related News

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PRNewswireDecember 19, 2024

Pharus Diagnostics LLC. (PharusDx), announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

OMT skeptical about effectiveness of Janssen Covid-19 vaccine after two weeks | Pharmasources.com

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Innovent Biologics announced that China's National Medical Products Administration (NMPA) has approved a New Drug Application (NDA) of DOVBLERON ® .

You may like
More>>

B28 pp 100ml autoclaved vaccine bottle

B28 pp 100ml autoclaved vaccine bottle
Inactivated Hepatitis A Vaccine

Inactivated Hepatitis A Vaccine
Real Time Multiplex RT-PCR Kit (for COVID-19)

Real Time Multiplex RT-PCR Kit (for COVID-19)
Animal Vaccine Filling Line

Animal Vaccine Filling Line
Recombinant Hepatitis B Vaccine

Recombinant Hepatitis B Vaccine
IPV(Inactivated Poliovirus Vaccine)

IPV(Inactivated Poliovirus Vaccine)
Influenza Vaccine(Split Virion),Inactivated

Influenza Vaccine(Split Virion),Inactivated
Influenza Vaccine, Live, Nasal, Freeze-dried

Influenza Vaccine, Live, Nasal, Freeze-dried
Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)

Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)
Human Vaccine

Human Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service